Human respiratory syncytial virus (RSV), a major cause of severe respiratory diseases, efficiently suppresses cellular innate immunity, represented by type I interferon (IFN), using its two unique nonstructural proteins, NS1 and NS2. In a search for their mechanism, NS1 was previously shown to decrease levels of TRAF3 and IKK, whereas NS2 interacted with RIG-I and decreased TRAF3 and STAT2. Here, we report on the interaction, cellular localization, and functional domains of these two proteins. We show that recombinant NS1 and NS2, expressed in lung epithelial A549 cells, can form homo-as well as heteromers. Interestingly, when expressed alone, substantial amounts of NS1 and NS2 localized to the nuclei and to the mitochondria, respectively. However, when coexpressed with NS2, as in RSV infection, NS1 could be detected in the mitochondria as well, suggesting that the NS1-NS2 heteromer localizes to the mitochondria. The C-terminal tetrapeptide sequence, DLNP, common to both NS1 and NS2, was required for some functions, but not all, whereas only the NS1 N-terminal region was important for IKK reduction. Finally, NS1 and NS2 both interacted specifically with host microtubule-associated protein 1B (MAP1B). The contribution of MAP1B in NS1 function was not tested, but in NS2 it was essential for STAT2 destruction, suggesting a role of the novel DLNP motif in protein-protein interaction and IFN suppression.
Human respiratory syncytial virus (RSV) is a member of the
Pneumovirus genus in the Paramyxoviridae family (9, 25) . RSV replicates primarily in the respiratory epithelium and is a leading cause of respiratory disease and asthma in the very young and the elderly (41, 42) . The nonsegmented negative-strand RNA genome of RSV encodes 10 genes, of which the two most promoterproximal and abundantly transcribed genes code for nonstructural proteins 1 and 2 (NS1 and NS2), which are small proteins, 139 and 124 amino acid residues long, respectively (9, 25) . The NS proteins circumvent the host innate immune system by preventing the induction of type I interferons (IFNs) as well as IFN-induced antiviral responses (6, 12, 20, 22, 23, 29, (33) (34) (35) (36) 39) , thus allowing a more robust replication of the virus, leading to the severe respiratory disease that characterizes RSV infection.
The IFN pathways of the cell can be divided into two functional ones, the IFN induction pathway, in which the cells produce IFN, and the IFN response pathway, in which the cells respond to exogenous IFN. One of the most proximal steps in the IFN induction pathway is the activation of the cytoplasmic RNA sensors of the RIG-I family (27, 37, 43, 44) . This triggers a cascade of signaling events whereby the CARD sequence of RIG-I interacts with and activates the CARD-like domaincontaining mitochondrial protein, MAVS (7, 18) . Activated MAVS then activates TRAF3 (7, 31) , which in turn activates two downstream kinases, IKKε and TBK1. The latter are Ser/ Thr kinases that phosphorylate the C-terminal domain of interferon regulatory factor 3 (IRF3) and IRF7, leading to their activation and translocation from the cytoplasm to the nucleus (7), where they activate the transcription of type I IFN genes (24, 32) . The synthesized type I IFNs are secreted outside the cell, where they bind to type I IFN receptors, triggering the IFN response pathway, which consists of another signaling cascade that eventually phosphorylates and activates transcription factors STAT1 and STAT2 and leads to transcriptional activation of a large family of IFN-responsive genes. Many genes in this family code for antiviral proteins, thus leading to the virusresistant state of the cell (4) .
In a previous study (36) , we reported that the NS1 protein of human RSV decreased the steady-state levels of TRAF3 and IKKε, whereas the predominant effect of NS2 was to decrease STAT2. These results provided a framework for the dual IFNsuppressive effects of the NS proteins, in which both the IFN induction and the IFN response pathways were suppressed. We also showed that NS1 and NS2 can bind with each other, independent of their C-terminal 10 residues, giving rise to the possibility of more-complex interactions with their targets and with accessory host proteins, if any. With the exception of our previous report (36) , no study to date has attempted to map the functional domains of NS proteins.
In the present study, we have extended the analysis of the functional domains of both NS proteins, characterized their homo-and heteromers, determined their intracellular locations, and identified the cellular microtubule-associated protein 1B (MAP1B) as a key accessory subunit of the functional NS complex. dishes were transiently transfected with either 4 g FLAG-TRAF3 or 2 g myc-IKKε expression plasmids. For STAT2, the endogenous protein was studied due to ease of detection. Cells were also transfected with 3 g of wild-type or N-terminally deleted (10 or 20 amino acids deleted) NS expression plasmids or with empty pCAGGS vector only. Cells were harvested, and IB was performed using the appropriate antibodies (FLAG, myc, or STAT2), as described in Materials and Methods. The graphs represent target band intensities after normalization to actin, averaged from three experiments, with error bars shown. In the STAT2 assay, NS1 was used as a negative control since it did not affect STAT2 (36) . Note that the deletions inhibited reductions of only IKKε by NS1 and STAT2 by NS2.
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the suspension was layered on top of 9 ml of IM containing 30% (vol/vol) Percoll and centrifuged for 30 min at 95,000 ϫ g. The mitochondrial band, approximately two-thirds down the tube, was recovered, diluted with IM, washed twice with IM by centrifugation, and resuspended in IM minus the BSA. Western or IB. To the nuclear, mitochondrial, and cytosolic fractions, an equal volume of 2ϫ Lammeli sample buffer was added, and the mixture was heated at 95°C for 5 min and subjected to sonication to reduce the viscosity.
For analysis of total cellular protein, A549 cells were harvested at 24-h posttransfection directly in 1ϫ Laemmli sample buffer, and the lysate was heated and sonicated as described above. All samples were then subjected to SDS-PAGE. Proteins were transferred to 0.45-m polyvinylidene difluoride (PVDF) membranes (Immobilon-P; Millipore) and probed using appropriate antibodies. SuperSignal West Femto substrate (Thermo Scientific) was used to develop the membranes using a Fujifilm LAS-1000 imaging system. When needed, densitometry of protein bands was performed using Fuji Image Gauge v4.0 software. Actin densitometry data were used as a control for normalization. Statistical graphs were generated from three or more repeat experiments.
IP. Experiments for MAP1B pulldown were performed using protein A-Sepharose (Sigma), as described previously (21) . Briefly, cell lysates containing approximately 300 to 500 g total protein were precleared by incubation at 4°C with 30 l of resuspended resin for 30 min and then incubated at 4°C for 4 h with 55 l of resuspended resin and 5 g of antibody per IP reaction. The resin was washed twice with 1ϫ PBS, and protein complexes were eluted by adding 40 l of 2ϫ sample buffer to each IP reaction and heating at 50°C for 15 min. Experiments for NS pulldown utilized the commercial anti-FLAG IP kit (Sigma FLAGIPT1) in which the anti-FLAG M2 antibody is covalently attached to the resin. For tandem affinity purification, the bound protein (FLAG-NS1) was eluted by 5ϫ resin volume of triple-FLAG peptide solution (1 mg/ml). The eluted material was then subjected to HA tag-based IP using anti-HA antibody and protein A-Sepharose as described above for FLAG-based IP, and the pellet analyzed by denaturing SDS-PAGE and Western blotting as needed.
Mass spectrometric analysis. Mass spectrometric analyses of protein complexes obtained from IP eluates were performed at the pay-for-service Proteomics Core facility of Louisiana State University, New Orleans, LA. To obtain a protein sample suitable for mass spectrometry analysis, the IP was done using the anti-FLAG M2 IP kit by Sigma; however, the protein complexes were eluted with 0.5 M NH 4 OH according to published protocols (8) .
Dual-luciferase assay. A549 cells were cotransfected with either the empty pCAGGS vector (control) or NS expression plasmid(s) along with IFN-␤-promoter-firefly-Luc and pCMV-Renilla-Luc vectors for the indicated duration. Promega's dual-luciferase reporter assay system (E1910) was used according to the manufacturer's protocol. Renilla luciferase activity served as an internal control for the normalization of the firefly luciferase activity. All experiments were performed in triplicates.
Immunofluorescence (IF). A549 cells were grown on 18-mm round coverslips placed in a 12-well plate. While still in the plate, cells were rinsed twice with cold PBS, fixed with ice-cold 10% trichloroacetic acid for 15 min, and then fixed for 3 min each in ice-cold 70%, 90%, and 100% ethanol, in that order. The cells were next rinsed twice with cold PBS for 5 min each, permeabilized with cold 0.2% Triton X-100 in PBS for 10 min, rinsed three times with PBS for 5 min each, and incubated for 2 h with primary antibody solution made in PBS. The unbound antibody was removed by washing three times with PBS, 5 min each, and the cells were incubated with an Alexa Fluor-conjugated secondary antibody in PBS, for 1.5 h in the dark. The cells were finally rinsed four times with PBS and mounted by using Gold reagent (Invitrogen) according to the manufacturer's instructions. Mouse anti-FLAG (Millipore; MAB 3118) and Alexa Fluor 488 donkey antimouse (Invitrogen; A21202) antibodies were used. Images were acquired in a Nikon TE2000E2 Perfect Focus fluorescence imaging microscope equipped with NIS-Elements 2.3 software.
Statistical analysis. Student's t test and one-way analysis of variance (ANOVA) were used to analyze all changes. A P value of Ͻ0.05 was considered significant.
RESULTS
Role of the N termini of the NS proteins. We first tested the ability of the N-terminal deletion mutants of NS proteins to alter FLAG-TRAF3 or myc-IKKε levels in transiently transfected A549 cells (Fig. 1) . We then conducted Luc-based reporter assays for the IFN-␤ promoter and the IFN-dependent ISGF54 gene promoter in the presence of these NS mutants (Fig. 2) ; ⌬NS1 ⌬NS2 RSV and recombinant IFN-␤ were used as the respective activators of these promoters. Results of these studies are described together below.
Deletions of the 10 N-terminal residues of NS1 had no effect on TRAF3 loss (Fig. 1A) ; deletion of 20 also had no effect, although we could not rule out that this was due to the poor expression of the protein. However, these deletions resulted in the restoration of IKKε levels (Fig. 1B) , which could underlie the higher IFN-␤ promoter activity observed in the Luc reporter assay ( Fig. 2A) . The same deletions also resulted in higher IFN-induced ISGF54 promoter activity (Fig. 2B ), indicating that this domain may have a role in suppressing IFN signaling as well, but through a mechanism other than STAT2, as NS1 did not degrade STAT2 (Fig. 1C) , confirming previous findings (36) .
The N-terminal deletions of NS2, in contrast, behaved essentially like full-length NS2 by all measures, i.e., they reduced TRAF3 and STAT2, and slightly increased IKKε (Fig. 1B) . Resembling the full-length protein, they also reduced IFN-␤ and ISGF54 promoter activities (Fig. 2) , likely due to their undiminished ability to reduce TRAF3 (Fig. 1A) and STAT2 ( Fig. 1C) , respectively. Overall, these results reveal a significant but modest role of the N termini of the NS proteins in their respective functions. Role of the C-terminal DLNP tetrapeptide of the NS proteins. We had previously generated recombinant NS1 and NS2 proteins lacking 10, 20, or 30 residues from the C terminus (36) . We then showed that the C-terminal 20 residues of NS1 were not required to decrease TRAF3 while its C-terminal 10 residues had a role in decreasing IKKε levels; in NS2, the C-terminal 10 residues were also absolutely required to decrease STAT2 (36) . We, therefore, proceeded to further pinpoint the structure-activity relationship of the C-terminal residues of both proteins.
We focused on the common DLNP tetrapeptide sequence, which is found at the very C terminus of both proteins. To investigate its possible role, mutant NS proteins lacking 1 to 4 residues from the C terminus were generated and tested. As expected from previous larger deletions and Luc reporter data (36), the NS1 ⌬DLNP (⌬C4) mutant was as active as fulllength NS1 in decreasing TRAF3 or IKKε levels, and thus, we show only the IKKε results here as representative (Fig. 3A) . In contrast, the DLNP sequence of NS2 was important for the increase of IKKε levels, since the loss of 3 or 4 residues of the tetrapeptide reduced this increase (Fig. 3A) . Progressive deletions of DLNP from NS2 also led to a gradual restoration of STAT2, with levels returning to normal when NS2 lost 3 (⌬LNP) or 4 (⌬DLNP) residues (Fig. 3B ). Taken together, the C-terminal DLNP tetrapeptide of NS2 is critical for its ability to increase IKKε and decrease STAT2, whereas the same sequence in NS1 was not important for its ability to decrease the steady-state levels of either IKKε or TRAF3.
Since STAT2 is a member of the IFN response pathway, we tested if the NS2 deletions above were also deficient in suppressing the IFN-responsive ISGF54 promoter. Indeed, the C-terminal deletions progressively lost this suppressive ability, as seen by the increasing Luc activity (Fig. 3C ). With NS1, the ⌬C10 deletion lost this ability, confirming our previous data; however, deletion of only DLNP (⌬C4) had no effect (Fig. 3C) , which led us to conclude that NS1 suppresses the IFN response through the use of the roughly six-residue region internal to DLNP and via a STAT2-independent mechanism.
The putative SOCS box sequence of the NS proteins. Recent studies of Elliot et al. (12) and ours (36) observed an internal sequence in both NS proteins that showed significant similarity to SOCS box motifs of the consensus sequence VXXLXXXC XXX, with the invariant Cys being at position 29 of NS1 and position 47 of NS2. As this motif occurs in archetypal E3 ligases, such as SOCS-1 to -3, and in VHL, it was conjectured that it might also enable NS proteins to act as E3 ligases (12, 36) . Because E3 ligases perform an essential step in proteasomal degradation of specific proteins, we have explored whether this mechanism underlies the observed decrease in the IFN-related targets of NS. To this end, we mutated the internal invariant Cys of this motif and tested its effect on the reduction of the NS targets. We found that the C29A and C47A mutation of NS1 and NS2, respectively, did not inhibit any of their functions (data not shown), which included a decrease of STAT2 by NS2, suppression of the IFNresponsive ISGF54 promoter by NS1 or NS2 (in the Luc reporter assay), decrease of TRAF3 by NS1 or NS2, and decrease and increase of IKKε, respectively, by NS1 and NS2. As we show below (Fig. 4) , the mutations also did not affect the ability of the NS proteins to dimerize with each other. Thus, 
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the role of the putative SOCS box in either NS protein, if any, remains uncertain. NS1 and NS2 heteromeric interaction. We previously showed that recombinant NS1 and NS2 formed a heteromer in the transfected cells and that the interaction did not require their C-10 termini (36) . Using available NS1 and NS2 antibodies, we also showed evidence for NS1-NS2 interaction in RSV-infected cells (36) . In continuation of these mapping experiments, we tested the interactions between the new mutants described in the previous sections: the ⌬N10 and ⌬N20 mutants and the SOCS-box Cys mutants. We coexpressed the FLAG-tagged mutant NS1 or NS2 with WT HA-tagged NS2 or NS1, respectively, in A549 cells for 24 h. Pulldown experiments were performed using anti-FLAG M2, and IP eluates were tested for the presence of HA-tagged NS proteins in IB using anti-HA. Interaction between wild-type NS1 and NS2 was confirmed, and all tested NS mutants were found capable of interacting with the other NS wild-type counterpart (Fig. 4) .
NS proteins can form homomers as well. To further investigate the ability of NS proteins to form higher-order structures that might allow them to achieve more complex and dynamic regulation of host signaling cascades, we investigated their ability to form homomers in the cellular environment. Briefly, A549 cells were cotransfected with FLAG-tagged NS1 or NS2 and HA-tagged NS1 or NS2, respectively, for 24 h. Next, pulldown experiments using anti-FLAG M2 were performed, and IP eluates were tested for the presence of HA-tagged NS proteins in IB using anti-HA. Interestingly, both NS proteins pulled down their self-molecules, indicating their ability to form homomers (Fig. 4) .
Both NS proteins interact with MAP1B. To explore potential cellular partners for NS proteins, we employed IP followed by mass spectrometric analysis of recombinant NS protein complexes. A549 cells were transiently transfected with expression plasmids for FLAG-NS1, FLAG-NS2, or both; a vector expressing the FLAG tag only served as a control. At 24 h posttransfection, cells were processed for IP using anti-FLAG M2 antibody. The IP eluates were then examined by mass spectrometric analysis, which identified multiple hits. Nonspecific hits obtained with the FLAG-only control were subtracted from FLAG-NS-transfected conditions. While a detailed analysis of individual NS-binding candidates is ongoing, the single host protein that associated with both NS1 and NS2 was the microtubule-associated protein 1B (MAP1B). The association was confirmed by IP with FLAG antibody to pull down the FLAG-tagged NS proteins, and IB with MAP1B antibody followed. Reciprocal IP with anti-MAP1B antibody followed by IB with anti-FLAG resulted in the detection of the NS proteins, further confirming the mass spectrometric result (Fig. 5) .
As DLNP is the longest common peptide sequence between the two NS proteins (and is also located at the same position in both (i.e., C terminal) and MAP1B is the only major host protein associated with both, we explored the possibility that MAP1B may associate via DLNP. Indeed, when the pulldown experiments were repeated following transient expression of DLNP-deleted (⌬C4) NS1 or NS2, no MAP1B could be detected in the pellet by IB (Fig. 5) .
We then tested if the NS1-NS2 heteromer binds MAP1B as well. We performed tandem affinity selection, in which we expressed FLAG-NS1 and HA-NS2 by cotransfection, and purified the heteromer by FLAG-based and then HA-based selection, in that order. The doubly selected complex was analyzed by immunoblotting with a MAP1B antibody, which revealed the presence of MAP1B in the NS1-NS2 heteromer (data not shown).
MAP1B is essential for the STAT2-decreasing activity of NS2. Since we found that the DLNP sequence is important for the ability of NS2 to bind MAP1B as well as to decrease STAT2, we reasoned that the two functions may be related. Thus, we directly tested if loss of MAP1B would also abrogate the ability of NS2 to decrease STAT2 levels. We transfected A549 cells with specific anti-MAP1B small interfering RNA (siRNA) and achieved nearly 80% reduction of MAP1B levels under optimal conditions. In these cells, recombinant NS2 indeed failed to decrease the endogenous STAT2 (Fig. 6) , suggesting an essential role of the NS2-MAP1B interaction in decreasing STAT2.
Intracellular locations of NS proteins. In previous preliminary studies of tagged recombinant NS proteins using indirect immunofluorescence, we observed both NS proteins in the cytoplasm and punctate spots of NS1 in the nucleus (36) . To more precisely localize both NS proteins, we undertook two complementary approaches, namely, microscopic observation and biochemical fractionation.
In the microscopy studies, we expressed tagged NS1 and NS2 individually and jointly by transfecting A549 cells with   FIG. 4 . Formation of homo-and heteromers by mutant as well as wild-type NS proteins. A549 cells in 10-cm 2 plates were cotransfected with 11.5 g each of the indicated FLAG-NS and HA-NS expression plasmids. At 24 h posttransfection, IP was performed using the FLAG-IP kit (Sigma), and then IB was performed on the IP eluates using anti-FLAG or anti-HA as shown. ␣, anti.
the recombinant plasmids and detected them by immunofluorescence using specific anti-tag antibodies. Since NS2 affects RIG-I (22) that signals through mitochondrial MAVS, we also specifically tested if either NS protein localizes to the mitochondria. Use of the mitochondrial marker, LETM1, indeed showed that a substantial portion of NS2 localized to mitochondria, while the rest was cytosolic (Fig. 7) . NS1, in contrast, was largely in the nucleus in distinct spots, and the rest was diffused through the cytosol. However, NS1 was not in the nucleolus, since the nuclear spots did not colocalize with fibrillarin, an established nucleolar marker. Finally, as NS1 and NS2 both are synthesized in RSV-infected cells, we investigated the location of these proteins when coexpressed recombinantly. Interestingly, in such cells, while NS2 still localized to the mitochondria, the majority of NS1 could now be found in the mitochondria as well, colocalizing with NS2 (Fig. 8) . It thus appears that the mitochondrial location of NS2 is dominant, such that it drives NS1 to the mitochondria as well, likely through the formation of the NS1-NS2 heteromer.
As microscopic detection is not quantitative, we adopted a biochemical approach to estimate the relative amounts of the NS proteins in the cellular compartments. We optimized the purification of the subcellular fractions and confirmed their purity by immunoblotting for marker proteins, namely, fibrillarin for nucleus, LETM1 for mitochondria, and eIF-2␣ for cytosol (Fig. 9A) . Immunoblotting of recombinant NS proteins, using FLAG antibody, revealed that approximately 80% of NS1 and NS2 were in the nuclei and mitochondria, respectively, whereas the rest is in the cytosol (Fig. 9B) . When NS1 and NS2 were coexpressed, however, nuclear NS1 disappeared with its concomitant appearance in the mitochondria, where NS2 resides. We then proceeded to confirm the NS1-NS2 colocalization in the actual virus-infected cell by using NS1 antibody made against (untagged) recombinant NS1. We could not use the NS2 antibody due to its poor efficiency in immunoblotting. Viral NS1 results clearly revealed about 80% of it in the mitochondria at all times of infection (Fig. 9C) . Since RSV infection generates both NS1 and NS2, these results corroborate the recombinant coexpression result that NS1 is located mitochondrially when NS2 is also present. FIG. 6. MAP1B is required for the STAT2-degrading activity of NS2. The indicated range of anti-MAP1B siRNA (Dharmacon ON-TARGET) was transfected into A549 cells using Oligofectamine as described, and the NS2 expression plasmid was transfected 8 h later. Cells were harvested at 24 h post-NS transfection and processed for Western blotting (IB) as described in the legend to Fig. 1 . Actin was used as internal control for equal sample loading. Note the reciprocal relationship between MAP1B and STAT2 levels in the presence of equal amounts of NS2 expressed.
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DISCUSSION
In this paper, we report our ongoing studies to further delineate the mechanism of action of the RSV NS proteins. The most important findings of this paper can be summarized as follows. (i) NS1 and NS2 can form homo-and heteromers, and this interaction did not require their termini. (ii) NS1 alone traffics to the nucleus, but NS2 alone, as well as the NS1-NS2 complex, traffics to the mitochondria. (iii) In the RSV-infected cell, the major portion of NS1 and NS2 appears to reside in the mitochondria, likely as a heteromer. (iv) The C-terminal tetrapeptide, DLNP, the only contiguous sequence common to both NS1 and NS2, is important for multiple IFN-suppressive functions, but most notably for binding to host microtubuleassociated protein 1B (MAP1B), which in turn is essential for the reduction of STAT2 by NS2.
We should add that the NS proteins did not affect the transcription of the IFN pathway genes. To test this, we measured the steady-state mRNA levels of all major genes of both the IFN activation and IFN response pathways in the presence and absence of NS proteins by quantitative reverse transcription-PCR (qRT-PCR) (38) , and no change was seen in the following gene mRNAs: RIG -I, MDA5, TRIM25, MAVS, TRAF3,  IKKε, TBK1, IRF3, IRF9, STAT2, TYK2, JAK1, TLR3 , and TLR4 (data not shown). We also tested the protein levels of RIG-I and MAVS, neither of which was affected by NS1 or NS2 (data not shown). It is thus likely that NS1 and NS2 selectively target a few strategic proteins, perhaps directly affecting their functions.
We present these results in the framework of a working model (Fig. 10) , the key feature of which is that NS1 and NS2 FIG. 7 . Predominantly nuclear and mitochondrial location, respectively, of singly expressed NS2 and NS1. A549 cells transfected with NS2 (A) or NS1 (B) were fixed and immunostained as described in Materials and Methods. The nuclear stain is always DAPI (4Ј,6-diamidino-2-phenylindole) (blue). For panel A, the majority of NS2, expressed alone, is in the mitochondria and not in the nucleus. In field 2, "a" is the NS2-transfected cell, and "b" is untransfected. For panel B, the majority of NS1, expressed alone, is in the nucleus but not in the nucleoli or in mitochondria. In field 1, two cells are shown, one with a newly replicated nucleus. Fibrillarin, the nucleolar marker, is pink. In field 2, images of another field, with colors as indicated; "a" is a NS1-transfected cell, and "b" is untransfected.
exist in various protein-protein complexes that dictate their intracellular location and function. The model should be considered approximate in the quantitative aspects, due to the technical difficulty of quantifying all NS complexes in the various locations. We also do not know whether a particular NS protein exhibits the same behavior as a homo-and a heteromer. For instance, we do not know if the NS2-NS1 complex degrades STAT2 as NS2 does. Overall, we have shown that three fundamentally distinct complexes of NS can be discerned, located as follows: NS1-NS1 in the nucleus and cytosol and NS2-NS2 and NS1-NS2 in the mitochondria and cytosol. Our results also suggest that in the actual RSV-infected cell, a large portion of the NS1 and NS2 reside in the mitochondria. Due to the potentially unequal reactivity of the two proteins to their respective antibodies, it is difficult to judge their relative amounts in the infected cell. Nevertheless, based on the band intensity of the FLAG-tagged proteins in the anti-FLAG immunoblot and the comparable levels of the two mRNAs in RSV-infected cells (2), we roughly estimate an equimolar ratio of NS1:NS2 in the heteromeric complex. In what follows, we discuss the potential roles of the various NS complexes in their respective cellular locations.
Of the known targets of NS proteins, RIG-I, STAT2, TRAF3, and IKKε are considered primarily cytosolic and hence likely to be targeted by the cytosolic fraction of the appropriate NS complexes. For example, as RIG-I and STAT2 are inhibited by NS2 (22, 36) , they may be acted upon by both NS2-NS2 and NS2-NS1, because both complexes contain NS2 as a subunit. TRAF3, in contrast, is reduced by both NS1 and NS2 and thus should be acted upon by all three species in the cytosol.
The significance of the mitochondrial and nuclear NS species is unclear at the moment, but it is tempting to speculate that they play important roles as well. Recall that NS2 inhibits RIG-I (22) ; if the mitochondrially located NS2-NS1 heteromer inhibits mitochondrial MAVS, it will further dampen signaling through this axis. RSV infection also regulates mitochondrial Bcl2 family members, specifically increasing the anti-apoptotic protein BclxL and decreasing the proapoptotic protein BimEL, thus shifting the balance toward net survival. Although the mechanism of this regulation remains unknown, we have previously shown that either NS1 or NS2 can suppress apoptosis (5) . Combining these two findings, we postulate that mitochondrial NS2 or NS2-NS1 may be involved in regulating the Bcl2 family members, thus modulating cell death. Nuclear NS1, constituting about 20% of the total NS1 in an RSV-infected cell (Fig. 9) , could have a variety of regulatory functions. RSV infection regulates the expression of a large number of host FIG. 8 . Modified intracellular location of NS1, when coexpressed with NS2. A549 cells were transfected with a mixture of NS1-and NS2-expressing plasmids, and cells were immunostained as described in Materials and Methods. The first two panels show mitochondrial localization of NS1 and NS2, respectively; the third panel shows colocalization of NS1 and NS2; the fourth panel is a merge of all three colors. Since all three available color filters (RGB) were used up to stain mitochondria, NS1, and NS2, the position of the nucleus is indicated approximately by the circular drawing. Note that these color keys differ from those in Fig. 7 , because different fluorophores were coupled to the secondary antibodies.
FIG. 9. Biochemical confirmation of NS1 and NS2 localization in subcellular fractions. Nuclei, mitochondria, and the cytosol (100,000 ϫ g supernatant) were purified from NS-transfected (B) or RSV-infected (C) A549 cells, as described in Materials and Methods, and each fraction was subjected to immunoblotting to detect the proteins as indicated. Each lane contained fractions originating from 2 ϫ 10 5 cells, and each blot is representative of a set of triplicates. T, total cell protein (before any fractionation); N, nuclei; M, mitochondria; C, cytosol. (A) Purity of representative subcellular fractions is shown through the detection of protein markers for nucleus (fibrillarin), mitochondria (LETM1), and cytosol (eIF-2␣). In panel B, for both NS1 and NS2, roughly 20% of the proteins are found in the cytosolic fraction. Note the movement of a large portion, although not all, of NS1 (asterisked band) from the nuclei to the mitochondria upon coexpression of NS2. In panel C, in the RSV-infected cell, where both NS1 and NS2 are produced by the virus early in infection (13) , note the location of NS1 in mitochondria at all time points (6 h to 24 h).
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on November 13, 2017 by guest http://jvi.asm.org/ genes (11) and a few microRNAs (our unpublished observation), some of which could be due to nuclear NS1. It is quite likely that many of these gene products will affect host-virus interaction and impact the pathology of infection. We now have two examples of one NS protein affecting the location and/or function of the other: the change of the NS1 location from nuclei to mitochondria in the presence of NS2 (Fig. 8 and 9) , and the opposing effects of NS1 and NS2 on IKKε, such that little or no net change in IKKε levels may occur when NS1 and NS2 are expressed together (36) . These results call for an in-depth analysis of the large body of literature in which recombinant RSV with deletion of a single NS gene was used to understand the mechanism of NS function. For example, infection with RSV⌬NS2, as opposed to wildtype RSV, will produce only NS1, which may decrease IKKε and regulate nuclear genes to a larger extent. Of note, neither NS1 nor NS2 had any effect on TBK (data not shown), a homologous kinase of the same family, thus demonstrating the stringent specificity of target choice.
The MAP1 family proteins are classical microtubule-associated proteins, known generally for their microtubule-stabilizing activity (14, 30) . Vertebrates contain three major family members, MAP1A, MAP1B, and a shorter isoform, MAP1S. All three are translated as larger proteins that are processed proteolytically to generate heavy and light chains, which in MAP1B, are 300 kDa and 32 kDa, respectively. While the two chains can form a heteromer, they also possess activities independent of each other, such as individual ability to interact with microtubules (14) . Indeed, we observed association of only the MAP1B heavy chain with the NS proteins, and not the light chain, suggesting the existence of a specific interaction domain that remains to be mapped. While the mechanistic role of MAP1B in NS function and localization remains to be determined, it is possible that NS-bound MAP1B serves to dock with mitochondrial receptors or recruit other host proteins that directly function for the NS complex, such as proteases that degrade STAT2 or other targets. The recruitment may involve domains of MAP1B as well as the NS protein, so that specificity is provided by the NS subunit of the complex. MAP1B is indeed known to serve as an adaptor and scaffold for several cellular proteins in other contexts (14, 30) . One such example is the Leu-rich acidic nuclear protein (LANP), essential for the differentiation of neural cells; it binds MAP1B and relocalizes from a perinuclear to a cytosolic distribution upon MAP1B light-chain coexpression (28) . No MAP1B-interacting protease is currently known, but new interacting partners of MAP1B are continually reported (26) . Regardless of the mechanism, this is the first report of viral IFN suppressors co-opting the host's MAP1B, a ubiquitous protein in all higher eukaryotes. It is an intriguing coincidence that lower eukaryotes, which lack MAP homologs, also generally lack an IFN system. For example, Drosophila, Caenorhabditis elegans, and Saccharomyces cerevisiae, lacking IFN, also contain single proteins (Futsch, LGG-2, and AUT7, respectively) that are only distantly related to mammalian MAP (14) . It is tempting to speculate that the NS proteins of RSV evolved to co-opt MAP1B to suppress IFN in those species in which IFN is a major antiviral mechanism.
These results, together with findings from our previous study (36) , lead us to conclude that NS proteins are multifunctional, in that they each target multiple components of IFN signaling and that each NS protein has specific domains required for specific effects. These results add to the diversity of mechanisms by which viruses of the Paramyxoviridae family evade IFN (4). Other members of this family, such as simian virus 5 (SV5), Newcastle disease virus (NDV), Sendai virus (SeV), measles virus, mumps virus, and parainfluenza virus, circumvent the IFN system by using the viral V proteins that use diverse mechanisms. Unlike the NS proteins of RSV, most V proteins selectively bind to MDA5 (1, 43) . NS2, in contrast, inhibits RIG-I (22) . The V proteins also inhibit signaling by various STAT proteins through diverse mechanisms, including proteasomal degradation, sequestration, and blockade of nuclear translocation (16) . NS2, in contrast, promotes STAT2 degradation by an apparently nonproteasomal protease (36) , the identity of which remains to be determined.
Lastly, knowledge of the functional domains of NS proteins should prove to be important in the construction of balanced attenuated vaccine strains that will allow a partial IFN response to protect the host while allowing attenuated viral replication to induce active immunity. Additionally, the targeting of virally important host factors is being recognized as a viable antiviral approach, alternative and complementary to the traditional approach of directly targeting viral gene products (15, 19) . MAP1B could thus become a target for RSV therapy by the use of microtubule inhibitors or siRNA-mediated knockdown of MAP1B. The additional benefit of microtubule inhibitors is that they will inhibit RSV replication as well (17) . While complete deletion of the MAP1B gene has been shown to cause developmental defects of the central and peripheral nervous systems, various knockout lines with partial MAP1B deletions that are viable with different degrees of phenotypes have been described, suggesting that MAP1B inhibition or downregulation in the short window of acute RSV therapy may be tolerable to the host.
